India to Canada: Apixaban Export Trade Route
India has recorded 673 verified shipments of Apixaban exported to Canada, representing a combined trade value of $33.0M USD. This corridor is served by 13 active Indian exporters, with an average shipment value of $49.0K USD. The leading Indian exporter is APOTEX RESEARCH PRIVATE LIMITED, which accounts for 54% of total export value with 297 shipments worth $17.8M USD. On the buying side, APOTEX INC, is the largest importer in Canada with $7.0M USD in purchases. The top 3 suppliers — APOTEX RESEARCH PRIVATE LIMITED, APOTEX RESEARCH PRIVATE LIMITED , INTAS PHARMACEUTICALS LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Apixaban corridor is one of India's established pharmaceutical export routes, with 673 shipments documented worth a combined $33.0M USD. The route is dominated by APOTEX RESEARCH PRIVATE LIMITED, which alone accounts for roughly 54% of all export value, reflecting the consolidated nature of India's apixaban manufacturing sector.
Across 13 active suppliers, the average shipment value stands at $49.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with apixaban's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 19.0%, placing it at rank #9 among India's top apixaban export destinations globally.
On the import side, key buyers of Indian apixaban in Canada include APOTEX INC,, APOTEX INC, APOTEX INC,-4100 WESTON ROAD and 38 others. APOTEX INC, is the single largest importer with 113 shipments valued at $7.0M USD.
